FENNEC PHARMACEUTICALS INC revenue breakdown overview

FENNEC PHARMACEUTICALS INC revenue for the last year amounted to 68.60 M CAD, the most of which — 65.13 M CAD — came from its highest performing source at the moment, Sodium Thiosulfate Injection, the year earlier bringing 28.68 M CAD. The greatest contribution to the revenue figure was made by United States — last year it brought FENNEC PHARMACEUTICALS INC 65.13 M CAD, and the year before that — 28.68 M CAD.